Matti Arstila
University of Turku
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Matti Arstila.
Circulation | 2000
Veikko Salomaa; Matti Niemelä; Heikki Miettinen; Matti Ketonen; Pirjo Immonen-Räihä; Seppo Koskinen; Markku Mähönen; Seppo Lehto; Tapio Vuorenmaa; Pertti Palomäki; Harri Mustaniemi; Esko Kaarsalo; Matti Arstila; Jorma Torppa; Kari Kuulasmaa; Pekka Puska; Kalevi Pyörälä; Jaakko Tuomilehto
BACKGROUND Low socioeconomic status (SES) is associated with increased coronary heart disease mortality rates. There are, however, very little data on the relation of SES to the incidence, recurrence, and prognosis of myocardial infarction (MI) events. METHODS AND RESULTS The FINMONICA MI Register recorded detailed information on all MI events among men and women aged 35 to 64 years in 3 areas of Finland during the period of 1983 to 1992. We carried out a record linkage of the MI register data with files of Statistics Finland to obtain information on indicators of SES, such as taxable income and education, for each individual who is registered. In the analyses, income was grouped into 3 categories (low, middle, and high), and education was grouped into 2 categories (basic and secondary or higher). Among men with their first MI event (n=6485), the adjusted incidence rate ratios were 1.67 (95% CI 1.57 to 1.78) and 1.84 (95% CI 1.73 to 1.95) in the low- and middle-income categories compared with the high-income category. For 28-day mortality rates, the corresponding rate ratios were 3.18 (95% CI 2.82 to 3.58) and 2.33 (95% CI 2.03 to 2.68). Significant differentials were observed for prehospital mortality rates, and they remained similar up to 1 year after the MI. Findings among the women were consistent with those among the men. CONCLUSIONS The excess coronary heart disease mortality and morbidity rates among persons with low SES are considerable in Finland. To bring the mortality rates of low- and middle-SES groups down to the level of that of the high-SES group constitutes a major public health challenge.
European Heart Journal | 2003
Veikko Salomaa; Matti Ketonen; Heli Koukkunen; Pirjo Immonen-Räihä; T. Jerkkola; Päivi Kärjä-Koskenkari; M. Mähönen; Matti Niemelä; Kari Kuulasmaa; P. Palomäki; Matti Arstila; T. Vuorenmaa; Aapo Lehtonen; Seppo Lehto; Heikki Miettinen; Jorma Torppa; Jaakko Tuomilehto; Y. A. Kesäniemi; K. Pyörälä
AIMS To analyse the trends in incidence, recurrence, case fatality, and treatments of acute coronary events in Finland during the 15-year period 1983-97. METHODS AND RESULTS Population-based MI registration has been carried out in defined geographical areas, first as a part of the FINMONICA Project and then continued as the FINAMI register. During the study period, 6501 coronary heart disease (CHD) events were recorded among men and 1778 among women aged 35-64 years. The CHD mortality declined on average 6.4%/year (95% confidence interval -5.4, -7.4%) among men and 7.0%/year (-4.7, -9.3%) among women. The mortality from recurrent events declined even more steeply, 9.9%/year (-8.3, -11.4%) among men and 9.3%/year (-5.1, -13.4%) among women. The proportion of recurrent events of all CHD events also declined significantly in both sexes. Of all coronary deaths, 74% among men and 61% among women took place out-of-hospital. The decline in 28-day case fatality was 1.3%/year (-0.3, -2.3%) among men and 3.1%/year (-0.7, -5.5%) among women. CONCLUSIONS The study period was characterized by a marked reduction in the occurrence of recurrent CHD events and a relatively modest reduction in the 28-day case fatality. The findings suggest that primary and secondary prevention have played the main roles in the decline in CHD mortality in Finland.
Circulation | 2003
Veikko Salomaa; Matti Ketonen; Heli Koukkunen; Pirjo Immonen-Räihä; T. Jerkkola; Päivi Kärjä-Koskenkari; Markku Mähönen; Matti Niemelä; Kari Kuulasmaa; Pertti Palomäki; J. Mustonen; Matti Arstila; Tapio Vuorenmaa; Aapo Lehtonen; Seppo Lehto; Heikki Miettinen; Jorma Torppa; Jaakko Tuomilehto; Y.A. Kesäniemi; Kalevi Pyörälä
Background—Out-of-hospital deaths constitute the majority of all coronary heart disease (CHD) deaths and are therefore of considerable public health significance. Methods and Results—We used population-based myocardial infarction register data to examine trends in out-of-hospital CHD deaths in Finland during 1983 to 1997. We included in out-of-hospital deaths also deaths in the emergency room and all deaths within 1 hour after the onset of symptoms. Altogether, 3494 such events were included in the analyses. The proportion of out-of-hospital deaths of all CHD deaths depended on age and gender. In the age group 35 to 64 years, it was 73% among men and 60% among women. These proportions did not change during the study. The annual average decline in the age-standardized out-of-hospital CHD death rate was 6.1% (95% CI, −7.3, −5.0%) among men and 7.0% (−10.0, −4.0%) among women. These declines contributed among men 70% and among women 58% to the overall decline in CHD mortality rate. In all, 58% of the male and 52% of the female victims of out-of-hospital CHD death had a history of symptomatic CHD. Among men with a prior history of myocardial infarction, the annual average decline in out-of-hospital CHD deaths was 5.3% (−7.2, −3.2%), and among men without such history the decline was 2.9% (−4.4, −1.5%). Among women, the corresponding changes were −7.8% (−14.2, −1.5%) and −4.5% (−8.0, −1.0%). Conclusions—The decline in out-of-hospital CHD deaths has contributed the main part to the overall decline in CHD mortality rates among persons 35 to 64 years of age in Finland.
Clinical Pharmacology & Therapeutics | 1974
Hannu Sundquist; Markku Anttila; Matti Arstila
Practolol and sotalol were found to differ qualitatively in their effects on blood pressure (BP). The reductions in both systolic and diastolic BP and in heart rate were largely unrelated to differences in dosage and serum concentrations of practolol in 22 patients with mild‐to‐moderate hypertension. On the other hand, when due to sotalol, these effects were dose related in 12 patients. From 200 to 800 mg of both drugs were given daily in two doses. The differences from the posttreatment of placebo systolic/diastolic BP were at a maximum at 400 mg of practolol: 22/6, 18/9, and 18/6 mm Hg in a standing, sitting, and supine position. In 8 patients who tolerated 600 mg of sotalol, the differences were, respectively, 29/14, 22/18, and 27/18 mm Hg. Side effects with sotalol were numerous when the heart rate fell below the critical level of about 48. The highest tolerated serum concentration of sotalol was about 5.1 mg/1. A 600 mg dose of sotalol was tolerated as well and as often as 800 mg of practolol. The serum concentrations of both drugs were closely related to the dose per kilogram of body weight.
Scandinavian Cardiovascular Journal | 1985
Erik Engblom; Matti Arstila; M. V. Inberg; Veikko Rantakokko; Esko Vättinen
The mortality rate and early complications of coronary artery bypass surgery were assessed for the first 441 consecutive patients operated on at Turku University Hospital. The overall hospital mortality rate was 2.5%. Perioperative myocardial infarction (PMI) accounted for more than half of the deaths, cerebral thromboembolism and sudden coronary death each for one-fifth and left ventricular failure for one-tenth. Postoperative complications occurred in 17.7% of the patients. Bleeding and postpericardiotomy syndrome were the most common complications (in 5.2 and 3.6% of the patients). Sternal resuture was needed in 3.2% of the patients, and PMI occurred in 2.9%. PMI had a 46% mortality rate, with two-thirds of the deaths occurring in the operating theatre. Only PMI reached statistical significance as sole cause of death. Mode of myocardial protection, completeness of revascularization and severity of coronary disease did not influence the PMI rate. Graft patency overall was 92.8% on average 3 months after surgery. The respective patency rates for internal mammary artery grafts and vein grafts were 90.3 and 92.9%.
Scandinavian Cardiovascular Journal | 1999
Pekka Porela; Kai-Petri Hänninen; Tapio Vuorenmaa; Matti Arstila; Kari Pulkki; Åse Bredbacka; Kari J. Antila; Jarmo Jalonen; Hans Helenius; Liisa-Maria Voipio-Pulkki
The purpose of this study was to investigate the applicability of computerized electrocardiogram interpretation in classifying patients with suspected acute myocardial infarction. Computerized acquisition and analysis of the 12-lead electrocardiogram can increase the consistency and reduce the workload of patient classification. The serial electrocardiograms of 311 consecutive patients with suspected myocardial infarction were studied and a new computerized myocardial infarction (CMI) electrocardiographic classification was developed and compared with one commercially available and two manual codes. Statistically, there was almost no correlation between the four ECG codes. Compared with the WHO enzymatic criteria, the sensitivity of the CMI code toward detecting definite and possible infarction was 69.2% and 29.8% with a specificity of 62.1% and 79.7%, respectively. In subjects without previous infarction (n = 214) the sensitivity of the CMI code for definite enzymatic infarction was 71.9% and specificity 77.6%. Substituting the CMI for the Minnesota code had no effect on patient classification by the WHO MONICA criteria in 78% of patients with first infarction. Judged by cardiac macromolecular leakage, all electrocardiographic classifications of possible infarction were poorly correlated with myocardial tissue injury. We have developed a new computerized coding system to detect electrocardiographic myocardial infarction. The structure of the code allows interactive redefinition of criteria to meet user-defined needs. However, because of the weak relationship between electrocardiographic and biochemical criteria of myocardial injury, the role of ECG in the diagnostic classification of acute ischemic syndromes should be re-evaluated.
Annals of Medicine | 1989
Helena Hämäläinen; Lars-Runar Knuts; Veikko Kallio; Olavi J. Luurila; Juha Hakkila; Matti Arstila; Llkka Vuori
An exercise test was performed in 306 patients who had had acute myocardial infarction one year previously. The five year cumulative coronary heart disease mortality was 40.0%, when the test had to be discontinued because of ventricular arrhythmias but only 13.0% if discontinued because of fatigue (P less than 0.05). If the maximum work load was less than 80 W the mortality was 30.7% compared with 16.6% in patients who exercised at least 80 W (P less than 0.01). If maximum systolic blood pressure was less than or equal to 150 mmHg mortality was 40.3% compared with 8.5% in patients with greater than 200 mgHg (P less than 0.001). The mortality was 38.2% in patients having single monoform ventricular ectopic beats at a rate of three or more per minute or multiform, paired or early cycle ventricular ectopic beats or ventricular tachycardias: this compared with 14.1% (P less than 0.001) in patients having no or only single monoform ventricular ectopic beats at a rate of less than three per minute. ST-segment depression in univariate testing had no prognostic value. When both exercise test and clinical variables were used in survival analysis (Coxs regression) the most important variable was heart volume and after that ventricular arrhythmias. In multivariate regression analysis ST segment depression also had additional prognostic value. Thus ventricular arrhythmias turned out to be the most important prognostic factor measured during exercise test.
European Heart Journal | 1992
J. Tuomilethto; Matti Arstila; E. Kaarsalo; J. Kankaanpää; Matti Ketonen; Kari Kuulasmaa; Seppo Lehto; Heikki Miettinen; H. Mustaniemi; P. Palomäki; P. Puska; K. Pyörälä; Veikko Salomaa; Jorma Torppa; T. Vuorenmaa
Pharmacology & Toxicology | 2009
Markku Anttila; Matti Arstila; Morris Pfeffer; Risto Tikkanen; Virve Vallinkoski; Hannu Sundquist
European Heart Journal | 1989
H. HāMāLāINEN; O. J. Luurila; Veikko Kallio; Lars-Runar Knuts; Matti Arstila; J. Hakkila
Collaboration
Dive into the Matti Arstila's collaboration.
University of Texas Health Science Center at San Antonio
View shared research outputs